Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder
- PMID: 29462768
- PMCID: PMC5889719
- DOI: 10.1016/j.drugalcdep.2017.12.023
Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder
Abstract
Objective: The purpose of this study was to describe postpartum contraceptive utilization patterns among women with OUD and evaluate the relationship between postpartum contraceptive method choice and interpregnancy interval.
Methods: A retrospective cohort study was conducted with women in Pennsylvania Medicaid with a diagnosis of OUD between 2008 and 2013. Postpartum contraceptive use within 90 days after delivery was identified through claims data and categorized by effectiveness (highly-effective, effective, and no method observed). Kaplan-Meier time-to-event analyses and multivariable-adjusted marginal Cox regression models were used to evaluate the relationship between postpartum contraceptive method choice and interpregnancy interval. Multivariable logistic regression analyses were used to identify risk factors predictive of a short interpregnancy interval (≤18 months).
Results: We identified 7805 women (9260 pregnancies) who had a diagnosis of OUD. Nearly three-quarters (74.5%) had no contraceptive method observed, 18.1% received an effective method, and only 7.4% received a highly-effective method (LARC or female sterilization) during the postpartum period. In Kaplan-Meier analyses, no significant differences were found in the time-to-next pregnancy interval when an effective contraceptive method vs. no contraceptive method was used. In multivariable analysis, predictors of a significantly longer interpregnancy interval were LARC use (HR 0.43, 95% CI 0.26-0.69), gestational hypertension (HR 0.80, 95% CI 0.65-0.97), and age (HR 0.95, 95% CI 0.94-0.96). Approximately 20% of women with OUD had a short interpregnancy interval.
Conclusion: Few women with OUD use highly-effective postpartum contraception, which is protective against short interpregnancy intervals.
Keywords: Contraception; Interpregnancy interval; Opioid use disorder; Postpartum; Pregnancy.
Copyright © 2018 Elsevier B.V. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Postpartum contraception: initiation and effectiveness in a large universal healthcare system.Am J Obstet Gynecol. 2017 Jul;217(1):55.e1-55.e9. doi: 10.1016/j.ajog.2017.02.036. Epub 2017 Feb 28. Am J Obstet Gynecol. 2017. PMID: 28257962
-
Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.Am J Obstet Gynecol. 2021 Mar;224(3):282.e1-282.e17. doi: 10.1016/j.ajog.2020.08.109. Epub 2020 Sep 6. Am J Obstet Gynecol. 2021. PMID: 32898503
-
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis.Addict Sci Clin Pract. 2025 Jan 6;20(1):1. doi: 10.1186/s13722-024-00530-1. Addict Sci Clin Pract. 2025. PMID: 39762993 Free PMC article.
-
Advances in contraception: new options for postpartum women.Expert Opin Pharmacother. 2017 May;18(7):677-688. doi: 10.1080/14656566.2017.1316370. Epub 2017 Apr 17. Expert Opin Pharmacother. 2017. PMID: 28375776 Review.
-
Immediate postpartum provision of long-acting reversible contraception.Curr Opin Obstet Gynecol. 2015 Dec;27(6):460-4. doi: 10.1097/GCO.0000000000000224. Curr Opin Obstet Gynecol. 2015. PMID: 26536209 Review.
Cited by
-
Contraceptive Method Choices in Women With and Without Opioid Use Who Have Infants in the Neonatal Intensive Care Unit and Nursery.Womens Health Rep (New Rochelle). 2020 Sep 24;1(1):375-382. doi: 10.1089/whr.2019.0025. eCollection 2020. Womens Health Rep (New Rochelle). 2020. PMID: 33786502 Free PMC article.
-
Contraceptive uptake in postpartum people with and without opioid use disorder and opioid use with co-occurring substance use.Drug Alcohol Depend Rep. 2024 Jun 24;12:100248. doi: 10.1016/j.dadr.2024.100248. eCollection 2024 Sep. Drug Alcohol Depend Rep. 2024. PMID: 39040479 Free PMC article.
-
Perinatal Opioid Use Disorder Research, Race, and Racism: A Scoping Review.Pediatrics. 2022 Mar 1;149(3):e2021052368. doi: 10.1542/peds.2021-052368. Pediatrics. 2022. PMID: 35156121 Free PMC article.
-
Planning postpartum contraception for women with substance use disorders: Utilisation of the birth admission.Aust N Z J Obstet Gynaecol. 2025 Apr;65(2):235-242. doi: 10.1111/ajo.13887. Epub 2024 Oct 21. Aust N Z J Obstet Gynaecol. 2025. PMID: 39428903 Free PMC article.
-
Postpartum Contraceptive Use, Pregnancy Intentions in Women With and Without a Delivery of a NAS-Affected Infant in Delaware, 2012-2018.Dela J Public Health. 2023 Jun 12;9(2):134-140. doi: 10.32481/djph.2023.06.025. eCollection 2023 Jun. Dela J Public Health. 2023. PMID: 37622155 Free PMC article.
References
-
- American College of Obstetrians and Gynecologists, Gynecologists' Committee on Obstetric Practice. Committee opinion No. 670: Immediate postpartum long-acting reversible contraception. Obstet Gynecol. 2016;128:e32–37. - PubMed
-
- American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol. 2011;118:184–196. - PubMed
-
- American College of Obstetrians Gynecologists, Gynecologists Committee on Gynecologic Practice, Long-Acting Reversible Contraception Working Group. ACOG committee opinion No. 450: Increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol. 2009;114:1434–1438. - PubMed
-
- Baldwin MK, Edelman AB. The effect of long-acting reversible contraception on rapid repeat pregnancy in adolescents: A review. J Adolesc Health. 2013;52:S47–53. - PubMed
-
- Black KI, Stephens C, Haber PS, Lintzeris N. Unplanned pregnancy and contraceptive use in women attending drug treatment services. Aust N Z J Obstet Gynaecol. 2012;52:146–150. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical